FDA Discovers Contaminated Products, Unsterile Conditions at Ameridose
USA Today report.
The report details a string of shortcomings, including ineffective drugs, unsterile or dilapidated environmental conditions and wildlife, at Ameridose. Sister company NECC is at the center of a federal investigation into a meningitis outbreak believed to be linked to contaminated NECC products. So far, the outbreak has claimed 32 lives and more than 400 meningitis illnesses.
Ameridose has already voluntarily recalled its products in late October after the FDA reported the company could not demonstrate product sterility and safety.
More Articles on Patient Safety:4 Risk Factors for Immediate Use Sterilization
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
Going from good to great: Why ASCs still need to improve infection controlRead Now
- Medicare inspections & survey readiness: Key concepts for success
- Streamlining the Life Safety Code® Survey
- International Anesthesia Research Society to issue $1.3M+ in research awards in 2015
- Top 10 common physician credentialing mistakes ASCs make
- Financial leadership playbook: The essential skills for a CFO in gastroenterology